BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11703602)

  • 1. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
    Mezzano D; Pais EO; Aranda E; Panes O; Downey P; Ortiz M; Tagle R; González F; Quiroga T; Caceres MS; Leighton F; Pereira J
    Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
    Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
    Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
    Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
    Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
    Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K
    Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
    McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
    Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation.
    Manrique J; Diáz A; Gavira JJ; Hernández A; Pujante D; Errasti P
    Transplant Proc; 2005 Nov; 37(9):3782-4. PubMed ID: 16386537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure.
    Mezzano D; Tagle R; Pais E; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Res; 1997 Dec; 88(6):465-72. PubMed ID: 9610957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
    Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
    Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.